(-0.46%) 5 025.75 points
(-0.38%) 37 864 points
(-0.72%) 17 422 points
(-0.53%) $82.29
(-0.74%) $1.744
(-0.07%) $2 396.40
(-0.18%) $28.33
(-1.31%) $942.00
(-0.01%) $0.939
(0.07%) $11.05
(0.01%) $0.804
(-0.72%) $93.22
Live Chart Being Loaded With Signals
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders...
Stats | |
---|---|
Today's Volume | 4.59M |
Average Volume | 446 108 |
Market Cap | 1.04M |
EPS | $0 ( 2024-03-26 ) |
Next earnings date | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0427 |
ATR14 | $0.0750 (443.79%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-04-21 | Sensenig Bethany | Sell | 9 100 | Common stock |
2023-03-29 | Sirgo Mark A | Buy | 7 885 | Common Stock |
2023-03-29 | Rice Yehuda Michael | Buy | 7 885 | Common Stock |
2023-03-29 | Johnson Lorin K | Buy | 7 885 | Common Stock |
2023-03-29 | Constantino Michael T. | Buy | 7 885 | Common Stock |
INSIDER POWER |
---|
96.62 |
Last 98 transactions |
Buy: 58 384 829 | Sell: 18 657 625 |
Volume Correlation
9 Meters Biopharma Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
9 Meters Biopharma Inc Correlation - Currency/Commodity
9 Meters Biopharma Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $0 |
Q1 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-1.160 |
Q4 | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-1.010 |
Q3 | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.770 |
Financial Reports:
No articles found.
9 Meters Biopharma Inc
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as well as in Phase IIa clinical trial for treatment of multi-system inflammatory syndrome; and Vurolenatide, a long-acting injectable glucagon-like-peptide-1 that is in Phase 2 clinical trial to treat short bowel syndrome. It also develops NM-102, a small molecule peptide; NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist for prevention of acute graft versus host disease; NM-136, a humanized monoclonal antibody for targeted obesity disorders; and NM-004, a double-cleaved mesalamine with an immunomodulator for rare and/or orphan indications. The company is based in Raleigh, North Carolina.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators